Registry for ME/CFS patients in Germany
Official title: Multi-Center Registry for ME/CFS, Including ME/CFS Following Epstein-Barr Virus-Associated Infectious Mononucleosis (EBV-IM) or Coronavirus Disease 2019 (Covid-19)
Run by Technical University of Munich · NCT05778006 · Data updated 2026-11-12
This study is creating a large registry to collect health information from people of all ages with ME/CFS in Germany, especially those affected by long-term COVID-19 effects, to help improve understanding and treatment of the condition.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 0 Years and up |
| Sex | All |
| Enrollment | 650 (estimated) |
| Sponsor | Technical University of Munich Academic / other |
| Locations | 1 site (Munich, Bavaria) |
| Status | Recruiting |
| Started | May 31, 2022 |
| Main results expected | May 31, 2052 |
| Study ends | May 31, 2052 |
| Registry record updated | January 10, 2025 |
| Trial ID | NCT05778006 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with ME/CFS based on internationally recognized criteria.
✕Probably not a fit
Patients who do not have a diagnosis of ME/CFS or cannot provide informed consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to establish a large-scale registry to collect data on the epidemiology, phenotypes, and disease trajectories of ME/CFS in Germany. It focuses on individuals of all ages affected by ME/CFS, particularly in the context of long-term effects following COVID-19 and other viral infections. The registry will facilitate future clinical trials by providing valuable insights into the condition and its management. The study will include patients diagnosed with ME/CFS based on established international criteria and will gather comprehensive health data.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of ME/CFS and lead to improved diagnosis and treatment options for patients.
How similar studies have gone: While there have been various studies on ME/CFS, this registry approach is relatively novel and aims to fill gaps in existing knowledge.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * ME/CFS diagnosis (ICD-10 G93.3) based on internationally established criteria * Informed consent by patients and/or guardian(s) Exclusion Criteria: * No ME/CFS (ICD-10 G93.3) * No informed consent
Where it's running
-
MRI Chronic Fatigue Center for Young People (MCFC) Children's Hospital, Technical University of Munich & Munich Municipal Hospital
Munich, Bavaria, Germany Recruiting
Study contacts
- Principal investigator: Uta Behrends, Prof. Dr. med. — MRI Chronic Fatigue Center for Young People (MCFC) Children's Hospital, Technical University of Munich & Munich Municipal Hospital
- Study coordinator: Uta Behrends, Prof. Dr. med.
- Email: uta.behrends@tum.de
- Phone: +4989 30682632
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cognitive rehabilitation for ME/CFS brain fog
Researchers are testing two cognitive rehabilitation approaches to see which helps adults with ME/CFS and brain fog better manage thinking and daily tasks.
-
Whole-body Cryotherapy for Fatigue in ME/CFS, Fibromyalgia, Long COVID
This study tests whether brief, repeated exposure to extreme cold can help reduce fatigue and related symptoms in adults with ME/CFS, fibromyalgia, or Long COVID compared to healthy controls.
-
Hyperbaric Oxygen Therapy for ME/CFS
This study tests whether hyperbaric oxygen therapy can help people with mild to moderate ME/CFS.
-
Immunoadsorption for autoantibody-positive post-infectious ME/CFS
This study will try immunoadsorption (a blood-filtering procedure) to remove autoantibodies in adults with infection-triggered ME/CFS, including cases after COVID, who have detectable antibodies.
-
Outreach medical care for housebound adults with Post-COVID syndrome or ME/CFS
This project will try home visits and remote assessments to learn the symptoms and care needs of adults who are housebound with Post‑COVID syndrome or ME/CFS.
-
Improving life for patients with chronic fatigue syndrome
This study is testing if two medications can help people aged 18-65 with chronic fatigue syndrome feel better and manage their symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.